Clinical Trials

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

Sep 23
3 min

Virpax selects Altasciences to develop a drug to prevent the spread of flu like viruses

AnQlar is a nanoparticle intended to help prevent the spread of negatively charged viruses such as COVID-19 and influenza...

Sep 15
4 min

Aclipse Therapeutics Expands Drug Development Pipeline for Gastroparesis

Aclipse Therapeutics is an innovative biopharmaceutical company developing life-changing treatments for patients with severe diseases.

Sep 13
5 min

Zevra Therapeutics Presents Full Data Set on the Cardiovascular Safety and Pharmacokinetics of SDX

These data play an important role in the development of KP1077 as we address the unmet needs of people living with rare sleep disorders

Aug 28
3 min

Inhibikase Therapeutics develops novel formulation of risvodetinib

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease...

Jul 24
3 min

PainReform, a clinical-stage specialty pharmaceutical company prices $2.7 million financing

PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure

Jul 19
2 min

Clinical stage biopharmaceutical company Galmed Pharmaceuticals prices $7 million public offering

Galmed Pharmaceuticals has focused almost exclusively on developing Aramchol for the treatment of NASH.

Jul 7
3 min

Liberate Medical raises $6.2 million to support trials of its VentFree Respiratory Muscle Stimulator

Liberate Medical is a medical device company that develops neuromuscular electrical stimulation technology

Jun 21
6 min

Turbine, which uses cell simulations increases its current financing to €25.5 million

Turbine's vision is to overcome the limitations in identifying oncology treatments with patient benefit by combining molecular biology...

Jun 2
5 min

Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure

Alleviant’s mission is to bring a safe, effective no-implant treatment option to millions of patients suffering from heart failure.

May 26
4 min

HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons

. NurrOn is focused on the discovering and developing novel therapies for people with neurodegenerative diseases including Parkinson's...

May 19
3 min

Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics

Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.

May 15
2 min

Sealonix raises $20 Million to develop sealants for abdominopelvic and orthopedic procedures

The PramStat patch builds on many years of research done by this experienced team, and now will move rapidly into clinical development.

May 12
6 min

Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction

Regentis’ current efforts are focused on orthopedic treatments using its Gelrin platform based on resorbable hydrogel implants to regenerate

May 11
3 min

Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

DehydraTECH evidenced an ability to deliver some drugs more effectively across the blood brain barrier.

May 3
4 min

Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials

We significantly grew our clinical trial programs for central nervous system cancers in 2022 and we expect to continue this momentum

Apr 25
2 min

ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP

ANI Pharmaceuticals (Nasdaq: ANIP) is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing,

Apr 19
2 min

Medical device company, BioVentrix closes on $48.5 million to improve cardiac function

BioVentrix is a medical device company focused on the development of less invasive therapies to treat the failing left ventricle.

Apr 18
4 min

Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

Aer Therapeutics is a clinical stage biopharmaceutical company with a mission to develop novel treatments for mucus-associated lung diseases

Apr 14
4 min

Novo Holdings participates in $105 million funding in Alentis Therapeutics

Alentis Therapeutics is a biotechnology company that focuses on developing treatments for CLDN1+ tumors and organ fibrosis.

Apr 3
3 min

Orion is building a pharmaceutical research ecosystem using data and artificial intelligence

Artificial intelligence-guided use of data is a competitive advantage when developing new innovative medicines.